There are errors in [Figure 5 (E)](#pone-0109218-g001){ref-type="fig"} of the published article. The authors have provided a corrected [Figure 5](#pone-0109218-g001){ref-type="fig"} here.

![K~v~1.3 siRNA abrogates neurotoxic activity of Tat- activated microglia.\
Microglia were transfected with siRNA targeting K~v~1.3 (K~v~1.3-siRNA) or nonspecific GAPD control siRNA (Ctrl-siRNAS) for 48 or 72 hr, followed by an additional 24 hr exposure to Tat (200 ng/ml). Cells were then harvested for detections of K~v~1.3 mRNA (48 hr post-transfection/24 hr Tat treatment) and K~v~1.3 proteins (72 hr post-transfection/24 hr Tat treatment). Supernatants were subjected to neuronal culture. Neuronal apoptosis and viability assay were determined using TUNEL staining and MTT assay. A: Representative gels show RT-PCR products for K~v~1.3 mRNA and internal control β-actin and bar graph reflects the density of each band after normalization of its β-actin. B: Western blots show K~v~1.3 protein and internal control β-actin protein expression of microglia, and bar graph shows densitometric quantification of each band. C: Collected supernatants were subjected to primary neuronal culture at a dilution of 1:5 for 24 hr and neuronal viability was evaluated by MTT assay. An increased viability was observed in neurons treated with supernatants recovered from microglia transfected with K~v~1.3-siRNA, but not transfected with Ctrl-siRNA. D: Transfection of microglia with K~v~1.3-siRNA significantly reduced neuronal apoptosis. In contrast, transfection of microglia with Ctrl-siRNA exhibited no significant protective effect. E: Apoptotic neurons were visualized by fluorescence microscopy at ×400 original magnification. Scale bar equals 100 µm. \* p\<0.05, \*\*\* p\<0.001 vs Ctrl-siRNA; ^\#\#\#^ p\<0.001 vs Ctrl (blank).](pone.0109218.g001){#pone-0109218-g001}
